OtherCellular and Molecular
A Single Point Mutation (N514Y) in the Human M3 Muscarinic Acetylcholine Receptor Reveals Differences in the Properties of Antagonists: Evidence for Differential Inverse Agonism
Mark R. Dowling, Jonathon M. Willets, David C. Budd, Steven J. Charlton, Stefan R. Nahorski and R.A. John Challiss
Journal of Pharmacology and Experimental Therapeutics February 17, 2006, DOI: https://doi.org/10.1124/jpet.106.101246
Mark R. Dowling
Jonathon M. Willets
David C. Budd
Steven J. Charlton
Stefan R. Nahorski
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherCellular and Molecular
A Single Point Mutation (N514Y) in the Human M3 Muscarinic Acetylcholine Receptor Reveals Differences in the Properties of Antagonists: Evidence for Differential Inverse Agonism
Mark R. Dowling, Jonathon M. Willets, David C. Budd, Steven J. Charlton, Stefan R. Nahorski and R.A. John Challiss
Journal of Pharmacology and Experimental Therapeutics February 17, 2006, DOI: https://doi.org/10.1124/jpet.106.101246
OtherCellular and Molecular
A Single Point Mutation (N514Y) in the Human M3 Muscarinic Acetylcholine Receptor Reveals Differences in the Properties of Antagonists: Evidence for Differential Inverse Agonism
Mark R. Dowling, Jonathon M. Willets, David C. Budd, Steven J. Charlton, Stefan R. Nahorski and R.A. John Challiss
Journal of Pharmacology and Experimental Therapeutics February 17, 2006, DOI: https://doi.org/10.1124/jpet.106.101246
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement